Abdominal Aortic Aneurysm (AAA) Repair Devices Market Size Worth USD 4.33 Billion by 2034 | CAGR: 5.0%

The abdominal aortic aneurysm repair devices market size is expected to reach USD 4.33 billion by 2034, according to a new study by Polaris Market Research. The report “Abdominal Aortic Aneurysm (AAA) Repair Devices Market Size, Share, Trend, Industry Analysis Report By Product Type (Endovascular Stent Graft System, Synthetic Graft System, Others), By Site, By End Use, By Region – Market Forecast, 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The abdominal aortic aneurysm repair devices market focuses on medical technologies designed to manage and treat aneurysms that develop in the abdominal aorta. These devices include endovascular stent grafts and surgical implants that help reinforce the weakened blood vessel and prevent rupture. The market is driven by a rising incidence of cardiovascular disorders and the aging population, which increases susceptibility to aneurysmal dilation. Growing preference for minimally invasive procedures has led to a significant shift toward endovascular aneurysm repair (EVAR), supported by faster recovery times, reduced surgical risk, and favorable clinical outcomes. Advancements in device design such as fenestrated grafts, improved delivery systems, and imaging compatibility are improving procedural success and expanding eligibility to more complex anatomies. Increasing patient awareness, screening programs, and improved diagnostic services are contributing to earlier detection and timely intervention.

The trend toward outpatient EVAR procedures is opening new channels for device deployment and cost optimization. Medical device manufacturers are investing in next-generation polymer sealing technologies and hybrid systems that enhance durability and long-term performance. There is also rising demand for personalized and anatomically adaptable devices that address the challenges of variable vessel morphology. The market offers significant opportunities for digital integration, including AI-powered imaging support, remote monitoring, and preoperative planning tools. Reimbursement improvements and regulatory support for novel solutions are further strengthening growth.

Top of FormAbdominal Aortic Aneurysm Repair Devices Market Report Highlights

• In 2025, North America dominated the global market with 43.1% revenue share. This is due to strong clinical adoption of endovascular aneurysm repair (EVAR) across hospitals and outpatient surgical centers.
• The Asia Pacific abdominal aortic aneurysm (AAA) repair devices market is expected to register the highest CAGR of 5.8% from 2026 to 2034. The growth is attributed to rising awareness of vascular health and increasing adoption of minimally invasive surgeries.
• In 2025, the endovascular stent graft system segment led with 68.4% revenue share. Growing adoption of minimally invasive techniques propels the segment growth.
• The infrarenal segment accounted for the largest revenue share of 74.2% in 2025. It is due to its high prevalence among abdominal aortic aneurysm cases and the availability of well-established EVAR treatment options.
• In 2025, the hospitals segment dominated with 71.6% revenue share. This is attributed to their comprehensive infrastructure, advanced imaging capabilities, and skilled vascular surgery teams.
• A few global key players include Medtronic, Endologix LLC, Gore Medical (W. L. Gore & Associates), MicroPort Scientific Corporation, Cook, JOTEC (Cryolife, Inc.), Cardinal Health, Terumo Corporation, and Lombard Medical.

Request a free sample copy or read the full market insights: Abdominal Aortic Aneurysm (AAA) Repair Devices Market

Polaris Market Research has segmented the abdominal aortic aneurysm repair devices market report on the basis of product type, site, end use, and region:

By Product Type Outlook (Revenue USD Billion, 2021–2034)

• Endovascular Stent Graft System
• Synthetic Graft System
• Others

By Site Outlook (Revenue USD Billion, 2021–2034)

• Infrarenal
• Pararenal

By End Use Outlook (Revenue USD Billion, 2021–2034)

• Hospitals
• Ambulatory Surgery Centers
• Clinics

By Regional Outlook (Revenue USD Billion, 2021–2034)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Vietnam
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa